Activity value 70india Supplier,Last transaction date:
2021-07-19
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for r p pharma from 2020 to 2021.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2021, the company has completed 945 transactions, with a transaction quantity of 1504495 and a transaction weight of 0.
5manoj
hong kongbuyer,they trade on 2017-05-05
20.05%
>
Products
Total 696
ProductsTransactionsPerDetail
bat 180051.28%>
tablet 139439.72%>
injection 40511.54%>
pharm 35510.11%>
capsule 2477.04%>
+View All
Hscode rank
Total 72
HSCode NameTransactionsPerDetail
HS 30049099215261.31%>
HS 3004904950114.27%>
HS 300490791815.16%>
HS 30049039752.14%>
HS 30019099561.6%>
+View All
Trading Area
Total 3
AreaTransactionsPerDetail
afghanistan386895.51%>
d.p.r.korea1804.44%>
hong kong20.05%>
Port statistics
Total 2
Port NameTransactionsPerDetail
delhi214652.99%>
tuglakabad icd intkd679019.51%>
r p pharma is india Supplier,
and primarily engages in the import and export business of products such as bat,tablet,injection.
According to the 52wmb.com global trade database, as of 2021-07-19, the company has completed 4050 international trades,
with its main trading regions covering afghanistan,d.p.r.korea,hong kong etc.
The core products include HS30049099,HS30049049,HS30049079 etc,
often transported via delhi,port tuglakabad icd intkd6 etc,
and its main trading partners are mubarak hashimi ltd.,korea potongmum co,mohammad rafi anwari co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on r p pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.